DOI:
10.1055/s-00042229
Geriatrie up2date
LinksClose Window
References
Hsia J, MacFadyen JG, Monyak J. et al.
Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol < 50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).
J Am Coll Cardiol 2011;
57: 1666-1675
doi:10.1016/j.jacc.2010.09.082
We do not assume any responsibility for the contents of the web pages of other providers.